Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study. [electronic resource]
Producer: 20141223Description: 242-8 p. digitalISSN:- 1748-5460
- Acetates -- therapeutic use
- Administration, Intranasal
- Adolescent
- Adult
- Androstadienes -- administration & dosage
- Anti-Allergic Agents -- therapeutic use
- Cyclopropanes
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Fluticasone
- Follow-Up Studies
- Glucocorticoids -- administration & dosage
- Histamine H1 Antagonists, Non-Sedating -- therapeutic use
- Humans
- Leukotriene Antagonists -- therapeutic use
- Male
- Middle Aged
- Outcome Assessment, Health Care
- Prospective Studies
- Quality of Life
- Quinolines -- therapeutic use
- Rhinitis, Allergic, Seasonal -- diagnosis
- Severity of Illness Index
- Sulfides
- Surveys and Questionnaires
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.